Evidence map›Paper›PMID 42718887›Full record

ArticleCancer communications (London, England)2026

The PROM1

Huijing Yin, Wei Wang, Jing Ge, Guangjian Fan, Jichao Shi, Ye Tian, Deping Kong, Fanyi Zhang, Jing Wei, Hongrui Zhan and 28 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer communications (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

Huijing YinPrecision Research Center for Refractory Diseases, Institute for Clinical Research, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Wei WangDepartment of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Jing GeShanghai Immune Therapy Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Guangjian FanPrecision Research Center for Refractory Diseases, Institute for Clinical Research, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Jichao ShiSchool of Materials Science and Engineering, Shanghai Institute of Technology, Shanghai, P. R. China.
Ye TianCore Facility of Basic Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Deping KongPrecision Research Center for Refractory Diseases, Institute for Clinical Research, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Fanyi ZhangDepartment of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Jing WeiBecton Dickinson Medical Devices (Shanghai) Co., Ltd., Shanghai, P. R. China.
Hongrui ZhanOE Biotech Co., Ltd., Shanghai, P. R. China.
Zhenyu XuOE Biotech Co., Ltd., Shanghai, P. R. China.
Jintong GeOE Biotech Co., Ltd., Shanghai, P. R. China.
Shuwei WangOE Biotech Co., Ltd., Shanghai, P. R. China.
Zhiming ZhangOE Biotech Co., Ltd., Shanghai, P. R. China.
Yunna ZhengOE Biotech Co., Ltd., Shanghai, P. R. China.
Zhifa ZhuOE Biotech Co., Ltd., Shanghai, P. R. China.
Qingzhen ZiOE Biotech Co., Ltd., Shanghai, P. R. China.
Xiaohua YaoOE Biotech Co., Ltd., Shanghai, P. R. China.
Yanting DingOE Biotech Co., Ltd., Shanghai, P. R. China.
Bo SongOE Biotech Co., Ltd., Shanghai, P. R. China.
Ruizhi LiOE Biotech Co., Ltd., Shanghai, P. R. China.
Liming FanOE Biotech Co., Ltd., Shanghai, P. R. China.
Hao YinOE Biotech Co., Ltd., Shanghai, P. R. China.
Yinghao JiangShanghai Maihui Biotechnology Co., Ltd., Shanghai, P. R. China.
Shaoqian ZhangAkoya Biosciences, Marlborough, MA, USA.
Xingning FuDepartment of Pathology, Weifang People's Hospital, Weifang, Shandong, P. R. China.
Jing WangPathology Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Yan ZhouCentral Laboratory, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P. R. China.
Haihua XueAccuramed Biotechnology Co., Limited, Shanghai, P. R. China.
Yannan QiuAccuramed Biotechnology Co., Limited, Shanghai, P. R. China.
Ling GeCenter for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, P. R. China.
Yuqin YangDepartment of Laboratory Animal Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Yinhui JinDepartment of Laboratory Animal Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Binbin LouStomatology Department, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Shuning DingDepartment of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Tao ZhangDepartment of Orthopedic Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
Denghui WeiState Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P. R. China.
Li ZhuDepartment of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AC133 AntigenBreast NeoplasmsErb-b2 Receptor Tyrosine KinasesNeoplastic Stem CellsSmad5 ProteinAnimalsCell Line, TumorFemaleGene Expression Regulation, NeoplasticHumansMiceMicroRNAsMultiomicsSpatial TranscriptomicsStromal CellsTumor MicroenvironmentAC133 AntigenERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesMicroRNAsPROM1 protein, humanSmad5 Protein

Identifiers

PMID42718887
PMCPMC13554431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.